e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
1,183.46
+1.57 (+0.13%)
Official Closing Price
Updated: 4:10 PM EDT, Sep 25, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,908,959
Open
1,185.32
Bid (Size)
1,182.44 (80)
Ask (Size)
1,184.76 (40)
Prev. Close
1,181.89
Today's Range
1,160.84 - 1,190.00
52wk Range
712.05 - 1,292.65
Shares Outstanding
956,580,893
Dividend Yield
0.58%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Could This Be Novo Nordisk’s Next Billion-Dollar Weight-Loss Product?
↗
Today 17:20 EDT
The drugmaker badly needs more clinical wins.
Via
The Motley Fool
Viking Therapeutics Soared After Its Latest GLP-1 Data. Is It Too Late to Buy?
↗
Today 6:25 EDT
The biotech player could eventually rival big pharma companies.
Via
The Motley Fool
Performance
YTD
+9.5%
+9.5%
1 Month
-4.1%
-4.1%
3 Month
+4.9%
+4.9%
6 Month
+31.9%
+31.9%
1 Year
+59.5%
+59.5%
More News
Read More
2 Healthcare Stocks with Impressive Fundamentals and 1 Facing Challenges
Today 0:35 EDT
Via
StockStory
AbbVie vs. Eli Lilly: Which Star Pharma Stock Is a Better Buy in 2026?
↗
September 24, 2026
Via
The Motley Fool
Eli Lilly (LLY) Stock Is Up, What You Need To Know
September 24, 2026
Via
StockStory
Explore the top gainers and losers within the S&P500 index in today's session.
↗
September 24, 2026
Via
Chartmill
XLV vs IBB: How Healthcare Diversification Compares to Biotech Concentration
↗
September 24, 2026
Via
The Motley Fool
Topics
ETFs
Fidelity Healthcare ETF (FHLC) vs. VanEck Biotech ETF (BBH): Which Fund Is the Better Buy?
↗
September 24, 2026
Via
The Motley Fool
Topics
ETFs
Stanley Druckenmiller, Ken Griffin, and Cathie Wood Have at Least 1 Thing in Common: They All Own This Stock
↗
September 24, 2026
Via
The Motley Fool
XLV vs. PJP: How Broad Healthcare Diversification Stacks Up to Pharma Stocks
↗
September 23, 2026
Via
The Motley Fool
Topics
ETFs
Could Retatrutide Be Worth $10 Billion to Eli Lilly?
↗
September 23, 2026
Via
The Motley Fool
Topics
Law Enforcement
Viking's Obesity Edge May Be Staying Power, Not Weight Loss
↗
September 23, 2026
Via
MarketBeat
Eli Lilly Keeps Pulling Ahead—Can Novo Nordisk Catch Up?
↗
September 23, 2026
Via
MarketBeat
Topics
Intellectual Property
Lawsuit
Why Viking Therapeutics Stock Skyrocketed on Tuesday
↗
September 23, 2026
Via
The Motley Fool
Better Healthcare ETF: Invesco's Biotech-Focused IBBQ vs. iShares' Broad IYH
↗
September 22, 2026
Via
The Motley Fool
Topics
ETFs
Novo Nordisk Has a Fresh New Name -- but It Still Faces the Same Old Problems
↗
September 22, 2026
Via
The Motley Fool
VHT vs. XBI: Is Diversified Healthcare Exposure or Biotech Stocks the Smarter Choice for Investors?
↗
September 22, 2026
Via
The Motley Fool
Topics
ETFs
Oura’s $15.6 Billion IPO Is Betting Investors See More Than a Smart Ring
↗
September 22, 2026
Via
MarketBeat
Topics
Initial Public Offering
Should Dividend Investors Buy Pfizer Stock for Its High Yield or Invest in Eli Lilly for Its Dividend Growth?
↗
September 22, 2026
Via
The Motley Fool
Topics
Economy
Viking Therapeutics Skyrockets On Obesity Drug Data. Eli Lilly, Novo Fall.
↗
September 22, 2026
Via
Investor's Business Daily
2 Cash-Producing Stocks with Exciting Potential and 1 We Brush Off
September 22, 2026
Via
StockStory
VivoSim Labs Inc. (NASDAQ: VIVS) Takes Aim at Pharma’s 92% Drug-Failure Problem
September 21, 2026
Via
AB Newswire
Topics
Animal Testing
Eli Lilly Stock Is On Track to Do Something It Hasn't Done Since 2016
↗
September 21, 2026
Via
The Motley Fool
Meet the Vanguard ETF That Increased Its SpaceX Holding by 39% in 1 Month and Shows No Signs of Slowing Down
↗
September 20, 2026
Via
The Motley Fool
Topics
ETFs
Why Twist Bioscience Stock Skyrocketed This Week
↗
September 18, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Frequently Asked Questions
Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 1,183.46
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 09/25/26 04:10 PM ET
What is the market capitalization of Eli Lilly?
The market capitalization of Eli Lilly is 1,132.08B
How many shares of Eli Lilly are outstanding?
Eli Lilly has 1,132B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.